Ron Ben-Menachem

CHOOSE BY ALPHABET

- NO VALUE - | A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W | Y | Z

Profile

Ron Ben-Menachem is a partner in the Corporate and Securities Departments. His practice focuses on private and public offerings and mergers and acquisitions, with a special emphasis on international transactions. Ron represents domestic and foreign clients in a broad range of industries, including financial services, technology, pharmaceuticals, energy and consumer products.

 Ron is the winner of the 2016 Deal Maker of the Year Award for his work on the $22 Billion notes offering by Teva Pharmaceuticls Industries, awarded by Finance Monthly magazine.

Ron is a winner of the 2013 Deal Maker of the Year Award for his work on the $1.4 billion global notes offering by Israel Electric Corporation awarded by Finance Monthly magazine.

Ron is rated as a "Leading Lawyer" by the International Financial Law Review (IFLR). 

Prior to joining HFN, Ron practiced corporate law with the New York office of Weil, Gotshal & Manges LLP (2004-2011) and clerked for the Honorable Justice Edmund E. Levy, Israel Supreme Court (2001).

Representative Transactions:

  • Mellanox Technologies's $811 million acquisition of EZchip Semiconductors.
  • Israeli counsel to a consortium of 10 banks, led by Barclays, Bank of America Merrill Lynch, Credit Suisse and HSBC in the public offering of Teva Pharmaceuticals Industries. Totalling $6.75 billion that was the largest equity offering by an Israeli company.
  • Israeli counsel to a consortium of banks, led by Barclays, Bank of America Merrill Lynch, Credit Suisse and HSBC in three public offerings of Teva Pharmaceuticals Industries, with an aggregate proceeds of approximately $22 billion. These offerings constitute the largest offerings ever by an Israeli company.
  • Representing Israel Electric Corporation in its 144/Reg S. public debt offerings: $1.4 billion in November 2014; $1.1 billion in June 2013; $500 million in February 2012.
  • Israeli counsel to Varonis Systems in its $105 million IPO on NASDAQ.
  • Representing Magic Software Enterprises in its $60 million public offering on NASDAQ.
  • Representing Foamix Pharmaceuticals in its $60 million public follow-on offering (April 2015) and its shelf registration in an amount of up to $150 million (October 2015), and with respect to their ongoing SEC reporting and compliance matters.
  • Israeli counsel to Imperva Inc. in connection with its $135 million follow-on offering on NYSE.
  • Israeli counsel to William Blair as underwriters of a $20 million public offering by RadCom on NASDAQ.
  • Israeli counsel to William Blair as underwriters in a $32 million public offering of AudioCodes Ltd. on NASDAQ.
  • Israeli counsel to Pfizer in the Spin-off of its animal health business, Zoetis.
  • Israeli counsel to Abbott Laboratories in the Spin-off of its research-based pharmaceutical business, Abbvie.
  • Representing Noy Infrastructure and Energy Fund in its investment in Metronit, Haifa’s light rail mass transit system.
  • Representing WeWork in their affairs in Israel. 

Education

  • Columbia Law School, USA, LL.M (cum laude), 2004
  • The Interdisciplinary Center (IDC), Herzliya, Israel, LL.B (cum laude), 2000
  • The Interdisciplinary Center (IDC), Herzliya, Israel, BA (Business Administration & Finance) (summa cum laude), 2000

Admitted to Practice

Country: 

New York

Year: 

2005

Country: 

Israel

Year: 

2001